These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20388212)

  • 1. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
    Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
    BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.
    Taghavi N; Biramijamal F; Sotoudeh M; Moaven O; Khademi H; Abbaszadegan MR; Malekzadeh R
    World J Gastroenterol; 2010 Oct; 16(39):4958-67. PubMed ID: 20954283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
    Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
    J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C
    Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
    Guan C; Shi H; Wang H; Zhang J; Ni W; Chen B; Hou S; Yang X; Shen A; Ni R
    J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
    Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
    Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Shih CH; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Int J Cancer; 2004 Apr; 109(4):483-90. PubMed ID: 14991568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
    Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
    Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
    Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
    Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
    Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.
    Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T
    Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.